BIB holdings
ProShares Ultra Nasdaq Biotechnology
Positions
267 stored of 267 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 201 | Solid Biosciences, Inc. | US83422E2046 | 83422E204 | 0.029% | $21K | Equity (common) | Corporate | United States | USD |
| 202 | Rigel Pharmaceuticals, Inc. | US7665597024 | 766559702 | 0.028% | $20K | Equity (common) | Corporate | United States | USD |
| 203 | Aclaris Therapeutics, Inc. | US00461U1051 | 00461U105 | 0.028% | $20K | Equity (common) | Corporate | United States | USD |
| 204 | Prothena Corp. plc | IE00B91XRN20 | Not reported | 0.027% | $20K | Equity (common) | Corporate | Ireland | USD |
| 205 | 4D Molecular Therapeutics, Inc. | US35104E1001 | 35104E100 | 0.025% | $19K | Equity (common) | Corporate | United States | USD |
| 206 | Aquestive Therapeutics, Inc. | US03843E1047 | 03843E104 | 0.025% | $18K | Equity (common) | Corporate | United States | USD |
| 207 | Allogene Therapeutics, Inc. | US0197701065 | 019770106 | 0.024% | $18K | Equity (common) | Corporate | United States | USD |
| 208 | Kyverna Therapeutics, Inc. | US5019761049 | 501976104 | 0.024% | $18K | Equity (common) | Corporate | United States | USD |
| 209 | Aura Biosciences, Inc. | US05153U1079 | 05153U107 | 0.024% | $18K | Equity (common) | Corporate | United States | USD |
| 210 | Fulcrum Therapeutics, Inc. | US3596161097 | 359616109 | 0.023% | $17K | Equity (common) | Corporate | United States | USD |
| 211 | Upstream Bio, Inc. | US91678A1079 | 91678A107 | 0.023% | $17K | Equity (common) | Corporate | United States | USD |
| 212 | Kamada Ltd. | IL0010941198 | Not reported | 0.023% | $17K | Equity (common) | Corporate | Israel | USD |
| 213 | Pacific Biosciences of California, Inc. | US69404D1081 | 69404D108 | 0.023% | $17K | Equity (common) | Corporate | United States | USD |
| 214 | First Tracks Biotherapeutics, Inc. | US3371851029 | 337185102 | 0.022% | $16K | Equity (common) | Corporate | United States | USD |
| 215 | Neurogene, Inc. | US64135M1053 | 64135M105 | 0.022% | $16K | Equity (common) | Corporate | United States | USD |
| 216 | C4 Therapeutics, Inc. | US12529R1077 | 12529R107 | 0.021% | $16K | Equity (common) | Corporate | United States | USD |
| 217 | Evolus, Inc. | US30052C1071 | 30052C107 | 0.021% | $16K | Equity (common) | Corporate | United States | USD |
| 218 | Lakefront Biotherapeutics NV | US36315X1019 | 36315X101 | 0.021% | $16K | Equity (common) | Corporate | Belgium | USD |
| 219 | Contineum Therapeutics, Inc. Contineum Therapeutics, Inc., Class A | US21217B1008 | 21217B100 | 0.021% | $15K | Equity (common) | Corporate | United States | USD |
| 220 | OmniAb, Inc. | US68218J1034 | 68218J103 | 0.020% | $14K | Equity (common) | Corporate | United States | USD |
| 221 | Altimmune, Inc. | US02155H2004 | 02155H200 | 0.019% | $14K | Equity (common) | Corporate | United States | USD |
| 222 | Enanta Pharmaceuticals, Inc. | US29251M1062 | 29251M106 | 0.019% | $14K | Equity (common) | Corporate | United States | USD |
| 223 | Vanda Pharmaceuticals, Inc. | US9216591084 | 921659108 | 0.019% | $14K | Equity (common) | Corporate | United States | USD |
| 224 | Larimar Therapeutics, Inc. | US5171251003 | 517125100 | 0.019% | $14K | Equity (common) | Corporate | United States | USD |
| 225 | Autolus Therapeutics plc | US05280R1005 | 05280R100 | 0.019% | $14K | Equity (common) | Corporate | United Kingdom | USD |
| 226 | Lexeo Therapeutics, Inc. | US52886X1072 | 52886X107 | 0.019% | $14K | Equity (common) | Corporate | United States | USD |
| 227 | Immuneering Corp. Immuneering Corp., Class A | US45254E1073 | 45254E107 | 0.019% | $14K | Equity (common) | Corporate | United States | USD |
| 228 | Lyell Immunopharma, Inc. | US55083R2031 | 55083R203 | 0.019% | $14K | Equity (common) | Corporate | United States | USD |
| 229 | Atea Pharmaceuticals, Inc. | US04683R1068 | 04683R106 | 0.018% | $13K | Equity (common) | Corporate | United States | USD |
| 230 | Puma Biotechnology, Inc. | US74587V1070 | 74587V107 | 0.018% | $13K | Equity (common) | Corporate | United States | USD |
| 231 | Cabaletta Bio, Inc. | US12674W1099 | 12674W109 | 0.018% | $13K | Equity (common) | Corporate | United States | USD |
| 232 | REGENXBIO, Inc. | US75901B1070 | 75901B107 | 0.018% | $13K | Equity (common) | Corporate | United States | USD |
| 233 | Keros Therapeutics, Inc. | US4923271013 | 492327101 | 0.017% | $13K | Equity (common) | Corporate | United States | USD |
| 234 | Editas Medicine, Inc. | US28106W1036 | 28106W103 | 0.017% | $12K | Equity (common) | Corporate | United States | USD |
| 235 | SIGA Technologies, Inc. | US8269171067 | 826917106 | 0.017% | $12K | Equity (common) | Corporate | United States | USD |
| 236 | Rocket Pharmaceuticals, Inc. | US77313F1066 | 77313F106 | 0.017% | $12K | Equity (common) | Corporate | United States | USD |
| 237 | Silence Therapeutics plc | US82686Q1013 | 82686Q101 | 0.016% | $12K | Equity (common) | Corporate | United Kingdom | USD |
| 238 | Invivyd, Inc. | US00534A1025 | 00534A102 | 0.016% | $12K | Equity (common) | Corporate | United States | USD |
| 239 | Neumora Therapeutics, Inc. | US6409791000 | 640979100 | 0.016% | $11K | Equity (common) | Corporate | United States | USD |
| 240 | Alpha Teknova, Inc. | US02080L1026 | 02080L102 | 0.015% | $11K | Equity (common) | Corporate | United States | USD |
| 241 | Anavex Life Sciences Corp. | US0327973006 | 032797300 | 0.014% | $10K | Equity (common) | Corporate | United States | USD |
| 242 | Entrada Therapeutics, Inc. | US29384C1080 | 29384C108 | 0.014% | $10K | Equity (common) | Corporate | United States | USD |
| 243 | AC Immune SA | CH0329023102 | Not reported | 0.013% | $10K | Equity (common) | Corporate | Switzerland | USD |
| 244 | Humacyte, Inc. | US44486Q1031 | 44486Q103 | 0.013% | $9K | Equity (common) | Corporate | United States | USD |
| 245 | Foghorn Therapeutics, Inc. | US3441741077 | 344174107 | 0.013% | $9K | Equity (common) | Corporate | United States | USD |
| 246 | Codexis, Inc. | US1920051067 | 192005106 | 0.013% | $9K | Equity (common) | Corporate | United States | USD |
| 247 | LENZ Therapeutics, Inc. | US52635N1037 | 52635N103 | 0.012% | $9K | Equity (common) | Corporate | United States | USD |
| 248 | Coherus Oncology, Inc. | US19249H1032 | 19249H103 | 0.012% | $9K | Equity (common) | Corporate | United States | USD |
| 249 | Quantum-Si, Inc. | US74765K1051 | 74765K105 | 0.012% | $9K | Equity (common) | Corporate | United States | USD |
| 250 | Voyager Therapeutics, Inc. | US92915B1061 | 92915B106 | 0.011% | $8K | Equity (common) | Corporate | United States | USD |
| 251 | Sagimet Biosciences, Inc. Sagimet Biosciences, Inc., Class A | US7867001049 | 786700104 | 0.011% | $8K | Equity (common) | Corporate | United States | USD |
| 252 | Arcturus Therapeutics Holdings, Inc. | US03969T1097 | 03969T109 | 0.011% | $8K | Equity (common) | Corporate | United States | USD |
| 253 | Orchestra BioMed Holdings, Inc. | US68572M1062 | 68572M106 | 0.011% | $8K | Equity (common) | Corporate | United States | USD |
| 254 | Caribou Biosciences, Inc. | US1420381089 | 142038108 | 0.011% | $8K | Equity (common) | Corporate | United States | USD |
| 255 | Bicycle Therapeutics plc | US0887861088 | 088786108 | 0.011% | $8K | Equity (common) | Corporate | United Kingdom | USD |
| 256 | NovaBridge Biosciences | US44975P1030 | 44975P103 | 0.010% | $8K | Equity (common) | Corporate | Cayman Islands | USD |
| 257 | Lifecore Biomedical, Inc. | US5147661046 | 514766104 | 0.009% | $7K | Equity (common) | Corporate | United States | USD |
| 258 | Tenaya Therapeutics, Inc. | US87990A1060 | 87990A106 | 0.009% | $7K | Equity (common) | Corporate | United States | USD |
| 259 | Jyong Biotech Ltd. | KYG831161065 | Not reported | 0.008% | $6K | Equity (common) | Corporate | Cayman Islands | USD |
| 260 | Black Diamond Therapeutics, Inc. | US09203E1055 | 09203E105 | 0.006% | $5K | Equity (common) | Corporate | United States | USD |
| 261 | Pyxis Oncology, Inc. | US7473241013 | 747324101 | 0.006% | $4K | Equity (common) | Corporate | United States | USD |
| 262 | PepGen, Inc. | US7133171055 | 713317105 | 0.005% | $4K | Equity (common) | Corporate | United States | USD |
| 263 | Rani Therapeutics Holdings, Inc. Rani Therapeutics Holdings, Inc., Class A | US7530181004 | 753018100 | 0.005% | $3K | Equity (common) | Corporate | United States | USD |
| 264 | Aardvark Therapeutics, Inc. | US0029421007 | 002942100 | 0.004% | $3K | Equity (common) | Corporate | United States | USD |
| 265 | Gossamer Bio, Inc. | US38341P1021 | 38341P102 | 0.003% | $2K | Equity (common) | Corporate | United States | USD |
| 266 | Cartesian Therapeutics, Inc. | US8162121128 | 816212112 | 0.000% | $0 | Other | Corporate | United States | USD |
| 267 | Third Harmonic Bio, Inc. | US88427A1079 | 88427A107 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |